(Q34424202)

2 August 2017

1 reference

title

Cognitive enhancement therapy for Alzheimer's disease. The way forward (English)

1 reference

2 August 2017

0 references

Parnetti L

1

1 reference

2 August 2017

Senin U

series ordinal

2

1 reference

2 August 2017

Mecocci P

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

2 August 2017

1 reference

2 August 2017

53

1 reference

2 August 2017

5

1 reference

2 August 2017

752-768

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199753050-00003

2 August 2017

0 references

cites work

Changes in protein kinases in brain aging and Alzheimer's disease. Implications for drug therapy

1 reference

12 December 2020

Idebenone in senile dementia of Alzheimer type: a multicentre study.

1 reference

12 December 2020

A pilot study of oral physostigmine plus yohimbine in patients with Alzheimer disease.

1 reference

12 December 2020

Desferrioxamine and Alzheimer's disease: video home behavior assessment of clinical course and measures of brain aluminum.

1 reference

12 December 2020

Superoxide radical scavenging activity of idebenone in vitro studied by ESR spin trapping method and direct ESR measurement at liquid nitrogen temperature

1 reference

12 December 2020

Intracerebroventricular administration of GM1 ganglioside to presenile Alzheimer patients

1 reference

12 December 2020

Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices

1 reference

12 December 2020

Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques

1 reference

12 December 2020

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

12 December 2020

Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor

1 reference

12 December 2020

Expression cloning of a rat B2 bradykinin receptor

1 reference

12 December 2020

Parenteral administration of GM1 ganglioside to presenile Alzheimer patients

1 reference

12 December 2020

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

1 reference

12 December 2020

Involvement of free radicals in excitotoxicity in vivo.

1 reference

12 December 2020

Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo

1 reference

12 December 2020

Randomized, double-blind, placebo controlled, multicentre study of idebenone in patients suffering from multi-infarct dementia.

1 reference

12 December 2020

The regulation of amyloid beta protein precursor secretion and its modulatory role in cell adhesion

1 reference

12 December 2020

Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype.

1 reference

12 December 2020

Neuroprotective effects of the pyrrolopyrimidine U-104067F in 3-acetylpyridine-treated rats

1 reference

12 December 2020

Brain Cytochrome Oxidase in Alzheimer's Disease

1 reference

12 December 2020

The clinical epidemiology of Alzheimer's disease

1 reference

12 December 2020

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

1 reference

12 December 2020

Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease.

1 reference

12 December 2020

Tacrine in Alzheimer's disease

1 reference

12 December 2020

Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein.

1 reference

12 December 2020

Differential involvement of protein kinase C isozymes in Alzheimer's disease

1 reference

12 December 2020

Effects of cholinesterase inhibitors and clonidine coadministration on rat cortex neurotransmitters in vivo

1 reference

12 December 2020

Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro

1 reference

12 December 2020

Cytokines in Alzheimer's disease

1 reference

12 December 2020

Anticholinesterase activity of a new carbamate, heptylphysostigmine, in view of its use in patients with Alzheimer-type dementia.

1 reference

12 December 2020

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

1 reference

12 December 2020

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

1 reference

12 December 2020

Clinical pharmacology of tetrahydroaminoacridine: a possible therapeutic agent Alzheimer's disease

1 reference

12 December 2020

Inflammation as a pathogenic mechanism in Alzheimer's disease.

1 reference

12 December 2020

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

1 reference

12 December 2020

Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.

1 reference

12 December 2020

An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain

1 reference

12 December 2020

Septal cholinergic afferents regulate expression of brain-derived neurotrophic factor and beta-nerve growth factor mRNA in rat hippocampus

1 reference

12 December 2020

Long-term and high-dose piracetam treatment of Alzheimer's disease.

1 reference

12 December 2020

Treatment of Alzheimer's disease: future directions.

1 reference

12 December 2020

Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

1 reference

12 December 2020

Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampus

1 reference

12 December 2020

Alzheimer's disease and caregiver time.

1 reference

12 December 2020

Complement activation and beta-amyloid-mediated neurotoxicity in Alzheimer's disease

1 reference

12 December 2020

Complement activation by beta-amyloid in Alzheimer disease

1 reference

12 December 2020

The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.

1 reference

12 December 2020

ESR spin trapping studies on the OH* free radical reactions of idebenone

1 reference

12 December 2020

Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation

1 reference

12 December 2020

Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease

1 reference

12 December 2020

Inflammatory mechanisms in Alzheimer's disease: implications for therapy

1 reference

12 December 2020

An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease.

1 reference

12 December 2020

The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth.

1 reference

12 December 2020

A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group

1 reference

12 December 2020

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

12 December 2020

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.

1 reference

12 December 2020

Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP.

1 reference

12 December 2020

Cerebral ischaemia, free radicals and antioxidant protection

1 reference

12 December 2020

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

1 reference

12 December 2020

B- Amyloid increases neuronal susceptibility to injufy by glucose deprivation

1 reference

12 December 2020

Are reactive oxygen species involved in Alzheimer's disease?

1 reference

12 December 2020

Interleukin-1 stimulates the beta-amyloid precursor protein promoter

1 reference

12 December 2020

Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease. Eptastigmine Study Group.

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

12 December 2020

Cortical cytochrome oxidase activity is reduced in Alzheimer's disease.

1 reference

12 December 2020

Secreted beta-APP stimulates MAP kinase and phosphorylation of tau in neurons

1 reference

12 December 2020

Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease.

1 reference

12 December 2020

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

1 reference

12 December 2020

Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study

1 reference

12 December 2020

Long-term idebenone treatment of vascular and degenerative brain disorders of the elderly.

1 reference

12 December 2020

Idebenone in the treatment of multi-infarct dementia: a randomised, double-blind, placebo controlled multicentre trial

1 reference

12 December 2020

Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum

1 reference

12 December 2020

Regulation of proteolytic processing of the amyloid beta-protein precursor by first messengers. A novel potential approach for the treatment of Alzheimer's disease.

1 reference

12 December 2020

GM1 ganglioside treatment facilitates behavioral recovery from bilateral brain damage.

1 reference

12 December 2020

Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II).

1 reference

12 December 2020

Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.

1 reference

12 December 2020

Role of neurotransmission in the regulation of amyloid beta-protein precursor processing

1 reference

12 December 2020

Brain membrane fluidity and lipid peroxidation in Alzheimer's disease.

1 reference

12 December 2020

Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: an analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat

1 reference

12 December 2020

Molecular cloning and expression of a rat V1a arginine vasopressin receptor

1 reference

12 December 2020

In situ dephosphorylation of tau by protein phosphatase 2A and 2B in fetal rat primary cultured neurons.

1 reference

12 December 2020

Rapid dephosphorylation of tau in heat-shocked fetal rat cerebral explants: prevention and hyperphosphorylation by inhibitors of protein phosphatases PP1 and PP2A

1 reference

12 December 2020

The role of beta-amyloid in the development of Alzheimer's disease

1 reference

12 December 2020

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

12 December 2020

Neuroimmunology of Alzheimer's disease: a conference report

1 reference

12 December 2020

Role of free radicals and catalytic metal ions in human disease: an overview

1 reference

12 December 2020

The stage specific temporal course of Alzheimer's disease: functional and behavioral concomitants based upon cross-sectional and longitudinal observation.

1 reference

12 December 2020

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

1 reference

12 December 2020

Reduction of low-molecular-weight acid phosphatase activity in Alzheimer brains.

1 reference

12 December 2020

10.2165/00003495-199753050-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference